Similar Articles
991 Sorafenib after resection improves the outcome of BCLC stage C hepatocellular carcinoma
992 High-dose hepatitis B immunoglobulin therapy in hepatocellular carcinoma with hepatitis B virus-DNA/hepatitis B e antigen-positive patients after living donor liver transplantation
993 Oncogenic Wnt3a expression as an estimable prognostic marker for hepatocellular carcinoma
994 Risk factors for local recurrence after en bloc endoscopic submucosal dissection for early gastric cancer
995 Hepatocellular carcinoma: Review of disease and tumor biomarkers
996 Host nucleotide polymorphism in hepatitis B virus-associated hepatocellular carcinoma
997 Comprehensive treatments for hepatocellular carcinoma with tumor thrombus in major portal vein
998 Dual-input two-compartment pharmacokinetic model of dynamic contrast-enhanced magnetic resonance imaging in hepatocellular carcinoma
999 Latest developments in precancerous lesions of hepatocellular carcinoma
1000 Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: A review
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA